9 studies found for:    15470213 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer
Condition: Castration-resistant Prostate Cancer
Intervention: Device: F-Choline-PET
2 Active, not recruiting Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: < 15% risk of + LN;   Radiation: > 15% risk of + LN
3 Completed Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies
Condition: Resistant Solid Malignancies
Interventions: Drug: Temsirolimus;   Drug: Docetaxel
4 Completed A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) Patients
Condition: Hormone-Refractory Prostate Cancer
Intervention: Drug: Docetaxel, Carboplatin
5 Completed F-18 Sodium Fluoride in Prostate Cancer
Condition: Prostate Neoplasm
Intervention: Drug: F-18 NaF
6 Recruiting Cultured Circulating Tumor Cells in Prostate and Other Cancers
Condition: Prostate Cancer
Intervention:
7 Recruiting Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: Alisertib;   Drug: Abiraterone acetate;   Drug: Prednisone
8 Suspended A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Docetaxel, PSK®;   Drug: Docetaxel, Placebo
9 Completed Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: PI-88;   Drug: docetaxel;   Drug: prednisone

Indicates status has not been verified in more than two years